Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study

British Journal of Cancer

Volumn 90, Issue 11, 2004, Pages 2131-2134

  Humphreys, A C ^a,f   Dent, J ^a   Rodwell, S ^a   Crawford, S M ^b   Joffe, J K ^c   Bradley, C ^d   Dodwell, D ^e   Perren, T J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b AIREDALE GENERAL HOSPITAL   (United Kingdom)

^c HUDDERSFIELD ROYAL INFIRMARY   (United Kingdom)

^d BRADFORD ROYAL INFIRMARY   (United Kingdom)

^e United Kingdom   (United Kingdom)

^f JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Epirubicin; Infusional 5 fluorouracil; Taxotere

Indexed keywords

DOCETAXEL; EPIRUBICIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG DOSE REDUCTION; FEBRILE NEUTROPENIA; FEMALE; HERPES ZOSTER; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; METASTASIS; MUCOSA INFLAMMATION; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEPSIS; TOXICITY TESTING;

EID: 3042783519     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601840     Document Type: Article

References (9)

1. Cardenal F, Montes A, Llort G, Segui J, Mesia R (1996) Typhlitis associated with docetaxel treatment. J Natl Cancer Inst 88: 1078-1079
2. Clemons M, Leahy M, Valle J, Jayson G, Ranson M, Howell A (1997) Review of recent trials of chemotherapy for advanced breast cancer: the taxanes. Eur J Cancer 33: 2183-2193
3. Jones AL, Smith IE, O'Brien ME, Talbot D, Walsh G, Ramage F, Robertshaw H, Ashley S (1994) Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen. J Clin Oncol 12: 1259-1265
4. Lortholary A, Maillard P, Delva R, Boisdron-Celle M, Perard D, Vernillet L, Besenval M, Gamelin E (2000) Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study. Eur J Cancer 36: 1773-1780
5. Miller KD, Sisk J, Ansari R, Gize G, Nattam S, Pennington K, Monaco F, Sledge Jr GW (2001) Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer. Oncology (Huntingt) 15: 38-40
6. Smith IE, Walsh G, Jones A, Prendiville J, Johnston S, Gusterson B, Ramage F, Robertshaw H, Sacks N, Ebbs S, Mckinna JA, Baum M (1995) High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. J Clin Oncol 13: 424-429
7. Trudeau M, Pagani O (2001) Epirubicin in combination with the taxanes. Semin Oncol 28: 41-50
8. Venturini M, Michelotti A, Papaldo P, Del Mastro L, Bergaglio M, Lionetto R, Lunardi G, Sguotti C, Frevola L, Donati S, Rosso R, Cognetti F (2001) Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients. Ann Oncol 12: 1097-1106
9. Viens P, Roche H, Kerbrat P, Fumoleau P, Guastalla JP, Delozier T (2001) Epirubicin - docetaxel combination in first-line chemotherapy for patients with metastatic breast cancer: final results of a dose-finding and efficacy study. Am J Clin Oncol 24: 328-335